Does the media favor TFX or ESTA?

In the previous week, Teleflex had 6 more articles in the media than Establishment Labs. MarketBeat recorded 10 mentions for Teleflex and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.75 beat Teleflex's score of 0.41 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teleflex 2 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ESTA or HAE?

In the previous week, Haemonetics had 3 more articles in the media than Establishment Labs. MarketBeat recorded 7 mentions for Haemonetics and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.75 beat Haemonetics' score of 0.32 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haemonetics 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ESTA or LIVN?

In the previous week, LivaNova had 5 more articles in the media than Establishment Labs. MarketBeat recorded 9 mentions for LivaNova and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.75 beat LivaNova's score of 0.56 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LivaNova 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ESTA or MMED?

In the previous week, MiniMed Group had 4 more articles in the media than Establishment Labs. MarketBeat recorded 8 mentions for MiniMed Group and 4 mentions for Establishment Labs. MiniMed Group's average media sentiment score of 1.29 beat Establishment Labs' score of 0.75 indicating that MiniMed Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, ESTA or ITGR?

Integer has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Establishment Labs $211.08M 10.00 -$51.06M -$1.28 N/A Integer $1.83B 2.36 $102.81M $2.98 42.50

Is ESTA or ITGR more profitable?

Integer has a net margin of 5.68% compared to Establishment Labs' net margin of -14.56%. Integer's return on equity of 11.84% beat Establishment Labs' return on equity. Company Net Margins Return on Equity Return on Assets Establishment Labs -14.56% -196.38% -10.45% Integer 5.68% 11.84% 5.98%

Does the media refer more to ESTA or ITGR?

In the previous week, Establishment Labs had 3 more articles in the media than Integer. MarketBeat recorded 4 mentions for Establishment Labs and 1 mentions for Integer. Integer's average media sentiment score of 1.88 beat Establishment Labs' score of 0.75 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Establishment Labs (ESTA) Competitors

$70.75 +2.13 (+3.10%)

Closing price 11/13/2026 04:00 PM Eastern

Extended Trading

$70.89 +0.14 (+0.20%)

As of 11/13/2026 07:30 PM Eastern

Compare

ESTA vs. TFX, HAE, LIVN, MMED, and ITGR

Should you buy Establishment Labs stock or one of its competitors? Establishment Labs's main competitors and comparable companies include Teleflex (TFX), Haemonetics (HAE), LivaNova (LIVN), MiniMed Group (MMED), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Establishment Labs compare to Teleflex?

Teleflex (NYSE:TFX) and Establishment Labs (NASDAQ:ESTA) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

Teleflex has a net margin of 13.51% compared to Establishment Labs' net margin of -14.56%. Teleflex's return on equity of 10.57% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	13.51%	10.57%	4.96%
Establishment Labs	-14.56%	-196.38%	-10.45%

Teleflex has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market.

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 10.0% of Establishment Labs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Establishment Labs has lower revenue, but higher earnings than Teleflex. Establishment Labs is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$1.99B	3.08	-$905.64M	$8.23	18.83
Establishment Labs	$211.08M	10.00	-$51.06M	-$1.28	N/A

In the previous week, Teleflex had 6 more articles in the media than Establishment Labs. MarketBeat recorded 10 mentions for Teleflex and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.75 beat Teleflex's score of 0.41 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	2 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Establishment Labs	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Teleflex presently has a consensus target price of $163.30, suggesting a potential upside of 5.36%. Establishment Labs has a consensus target price of $95.00, suggesting a potential upside of 34.28%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts plainly believe Establishment Labs is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.58
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80

Summary

Teleflex beats Establishment Labs on 9 of the 17 factors compared between the two stocks.

How does Establishment Labs compare to Haemonetics?

Establishment Labs (NASDAQ:ESTA) and Haemonetics (NYSE:HAE) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

In the previous week, Haemonetics had 3 more articles in the media than Establishment Labs. MarketBeat recorded 7 mentions for Haemonetics and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.75 beat Haemonetics' score of 0.32 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Haemonetics	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 2.1% of Haemonetics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Haemonetics has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	10.00	-$51.06M	-$1.28	N/A
Haemonetics	$1.33B	4.20	$97.31M	$2.23	55.23

Haemonetics has a net margin of 7.52% compared to Establishment Labs' net margin of -14.56%. Haemonetics' return on equity of 27.42% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-14.56%	-196.38%	-10.45%
Haemonetics	7.52%	27.42%	9.77%

Establishment Labs has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Haemonetics has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

Establishment Labs presently has a consensus price target of $95.00, indicating a potential upside of 34.28%. Haemonetics has a consensus price target of $129.00, indicating a potential upside of 4.74%. Given Establishment Labs' higher probable upside, equities analysts clearly believe Establishment Labs is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80
Haemonetics	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.83

Summary

Haemonetics beats Establishment Labs on 11 of the 17 factors compared between the two stocks.

How does Establishment Labs compare to LivaNova?

Establishment Labs (NASDAQ:ESTA) and LivaNova (NASDAQ:LIVN) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk.

Establishment Labs currently has a consensus price target of $95.00, indicating a potential upside of 34.28%. LivaNova has a consensus price target of $101.22, indicating a potential upside of 10.84%. Given Establishment Labs' stronger consensus rating and higher possible upside, equities research analysts clearly believe Establishment Labs is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80
LivaNova	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, LivaNova had 5 more articles in the media than Establishment Labs. MarketBeat recorded 9 mentions for LivaNova and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.75 beat LivaNova's score of 0.56 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LivaNova	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Establishment Labs has higher earnings, but lower revenue than LivaNova. Establishment Labs is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	10.00	-$51.06M	-$1.28	N/A
LivaNova	$1.39B	3.62	-$242.47M	$3.00	30.44

Establishment Labs has a beta of 1.03, indicating that its share price is 3% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.91, indicating that its share price is 9% less volatile than the broader market.

LivaNova has a net margin of 13.01% compared to Establishment Labs' net margin of -14.56%. LivaNova's return on equity of 16.10% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-14.56%	-196.38%	-10.45%
LivaNova	13.01%	16.10%	7.85%

Summary

LivaNova beats Establishment Labs on 8 of the 15 factors compared between the two stocks.

How does Establishment Labs compare to MiniMed Group?

Establishment Labs (NASDAQ:ESTA) and MiniMed Group (NASDAQ:MMED) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

Establishment Labs presently has a consensus price target of $95.00, indicating a potential upside of 34.28%. MiniMed Group has a consensus price target of $24.13, indicating a potential upside of 34.10%. Given Establishment Labs' stronger consensus rating and higher probable upside, equities research analysts clearly believe Establishment Labs is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80
MiniMed Group	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.68

MiniMed Group has a net margin of 0.00% compared to Establishment Labs' net margin of -14.56%. MiniMed Group's return on equity of 0.00% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-14.56%	-196.38%	-10.45%
MiniMed Group	N/A	N/A	N/A

72.9% of Establishment Labs shares are held by institutional investors. 10.0% of Establishment Labs shares are held by company insiders. Comparatively, 0.0% of MiniMed Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, MiniMed Group had 4 more articles in the media than Establishment Labs. MarketBeat recorded 8 mentions for MiniMed Group and 4 mentions for Establishment Labs. MiniMed Group's average media sentiment score of 1.29 beat Establishment Labs' score of 0.75 indicating that MiniMed Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	3 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Establishment Labs has higher earnings, but lower revenue than MiniMed Group. Establishment Labs is trading at a lower price-to-earnings ratio than MiniMed Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	10.00	-$51.06M	-$1.28	N/A
MiniMed Group	$3.10B	1.63	-$333M	-$0.68	N/A

Summary

MiniMed Group beats Establishment Labs on 9 of the 15 factors compared between the two stocks.

How does Establishment Labs compare to Integer?

Establishment Labs (NASDAQ:ESTA) and Integer (NYSE:ITGR) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

Establishment Labs currently has a consensus target price of $95.00, indicating a potential upside of 34.28%. Integer has a consensus target price of $113.67, indicating a potential downside of 10.25%. Given Establishment Labs' stronger consensus rating and higher probable upside, research analysts clearly believe Establishment Labs is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80
Integer	0 Sell rating(s)	11 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.08

Integer has a net margin of 5.68% compared to Establishment Labs' net margin of -14.56%. Integer's return on equity of 11.84% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-14.56%	-196.38%	-10.45%
Integer	5.68%	11.84%	5.98%

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Establishment Labs had 3 more articles in the media than Integer. MarketBeat recorded 4 mentions for Establishment Labs and 1 mentions for Integer. Integer's average media sentiment score of 1.88 beat Establishment Labs' score of 0.75 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Integer has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	10.00	-$51.06M	-$1.28	N/A
Integer	$1.83B	2.36	$102.81M	$2.98	42.50

Establishment Labs has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Integer has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

Summary

Integer beats Establishment Labs on 9 of the 16 factors compared between the two stocks.

Get Establishment Labs News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ESTA vs. The Competition

Export

Metric	Establishment Labs	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.05B	$5.96B	$7.84B	$12.19B
Dividend Yield	N/A	1.68%	2.46%	4.53%
P/E Ratio	-55.27	38.39	34.71	28.44
Price / Sales	10.00	5.57	8.66	5.84
Price / Cash	N/A	23.95	21.93	22.49
Price / Book	136.06	4.45	4.35	3.76
Net Income	-$51.06M	$143.14M	$3.51B	$390.55M
7 Day Performance	5.57%	-1.25%	-1.49%	-0.33%
1 Month Performance	15.30%	-1.30%	-2.55%	-4.82%
1 Year Performance	10.56%	1.73%	0.92%	-5.83%

Establishment Labs Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ESTA Establishment Labs	3.3549 of 5 stars	$70.75 +3.1%	$95.00 +34.3%	N/A	$2.05B	$211.08M	N/A	1,004
TFX Teleflex	3.8189 of 5 stars	$155.71 +0.6%	$163.30 +4.9%	N/A	$6.60B	$1.99B	18.92	15,500
HAE Haemonetics	2.0451 of 5 stars	$120.81 +2.2%	$126.38 +4.6%	N/A	$5.50B	$1.33B	54.17	3,009	Analyst Forecast Insider Trade
LIVN LivaNova	2.498 of 5 stars	$89.80 -3.0%	$101.22 +12.7%	N/A	$4.95B	$1.39B	29.97	3,300	Insider Trade
MMED MiniMed Group	3.592 of 5 stars	$17.39 -2.8%	$24.25 +39.5%	N/A	$4.89B	$3.10B	N/A	2,800	Analyst Forecast Options Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ESTA) was last updated on 11/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Establishment Labs (ESTA) Competitors

ESTA vs. TFX, HAE, LIVN, MMED, and ITGR

How does Establishment Labs compare to Teleflex?

Summary

How does Establishment Labs compare to Haemonetics?

Summary

How does Establishment Labs compare to LivaNova?

Summary

How does Establishment Labs compare to MiniMed Group?

Summary

How does Establishment Labs compare to Integer?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESTA vs. The Competition

Establishment Labs Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Establishment Labs (ESTA) Competitors

ESTA vs. TFX, HAE, LIVN, MMED, and ITGR

How does Establishment Labs compare to Teleflex?

Is TFX or ESTA more profitable?

Which has more volatility and risk, TFX or ESTA?

Do institutionals & insiders have more ownership in TFX or ESTA?

Which has stronger earnings & valuation, TFX or ESTA?

Does the media favor TFX or ESTA?

Do analysts rate TFX or ESTA?

Summary

How does Establishment Labs compare to Haemonetics?

Does the media prefer ESTA or HAE?

Do institutionals and insiders believe in ESTA or HAE?

Which has preferable valuation & earnings, ESTA or HAE?

Is ESTA or HAE more profitable?

Which has more volatility & risk, ESTA or HAE?

Do analysts recommend ESTA or HAE?

Summary

How does Establishment Labs compare to LivaNova?

Do analysts rate ESTA or LIVN?

Does the media prefer ESTA or LIVN?

Do insiders and institutionals believe in ESTA or LIVN?

Which has higher earnings and valuation, ESTA or LIVN?

Which has more volatility and risk, ESTA or LIVN?

Is ESTA or LIVN more profitable?

Summary

How does Establishment Labs compare to MiniMed Group?

Do analysts rate ESTA or MMED?

Is ESTA or MMED more profitable?

Do insiders and institutionals hold more shares of ESTA or MMED?

Does the media prefer ESTA or MMED?

Which has higher valuation and earnings, ESTA or MMED?

Summary

How does Establishment Labs compare to Integer?

Do analysts recommend ESTA or ITGR?

Is ESTA or ITGR more profitable?

Do institutionals and insiders believe in ESTA or ITGR?

Does the media refer more to ESTA or ITGR?

Which has higher earnings and valuation, ESTA or ITGR?

Which has more volatility & risk, ESTA or ITGR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESTA vs. The Competition

Establishment Labs Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools